व्हल्व्हल किंवा योनीचा कर्करोग
Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study.
कुठे जायचं
या ट्रायलसाठी भारतातील १ हॉस्पिटल रुग्णांना घेत आहे.
रजिस्ट्री सारांश (तांत्रिक)
The vaginal cancers are responsible for 2% of gynecological cancer while vulvar cancers account for 4 % of gynecological cancers. HPV 16 and 33 are most prevalent in vaginal cancers and account for more than half of cases HPV related vaginal cancer. However, adeqaute information is not there. Similarly, structured QOL data is not available for India. Therefore, in the proposed study we will like to systematically evaluate the patterns of relapse and disease outcomes in patients with vulvovaginal cancer treated with radiation (+/- chemotherapy). The therapeutic research in vulvo-vaginal cancers…
Sponsor: टाटा मेमोरियल हॉस्पिटल
NCT07179757 on ClinicalTrials.gov
Last updated on the registry 4 Feb 2026 · read by us 20 Oct 2026